Patent EP0156537A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0156537A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Biological magnetic fluids

Assignee: The University of Texas System
•
Filing: 1985-03-01
•
Granted: —
•
Expires: 2005-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biological magnetic fluid includes a magnetic colloidal disperse phase distributed throughout a liquid dispersion medium. The disperse phase may be made up of magnetic particles coated with cross-linked biologically compatible polymers. The biologically compatible polymers may be connected by way of covalent linkages to biologically active macromolecules. This may be accomplished by covalently linking immunoglobulin to the biologically compatible polymers and then attaching antibodies with predefined specificity to the immunoglobulin. These antibodies may target the magnetic particles on desired cells, for a variety of medical applications. The magnetic particles may be made up of magnetite cores with cobalt or cobalt and boron coatings. In addition magnetic particles may be made of icobalt and boron with the boron being in sufficient concentration to enable radiation activation. The magnetic colloid may be formed by incorporating the biologically compatible polymer into the colloid as the colloid is being formed by reducing a magnetic metallic salt. The colloid is advantageously produced in a multi-stage process in order to achieve very uniform particle sizes. The magnetic colloid may also be made by forming a biologically incompatible magnetic colloid, and slowly adding the colloid to a vigorous I biologically compatible polymer. These biological magnetic fluids are useful, for example, in separating cancerous cells from normal cells in bone marrow transplants.

Inventors

  • 👤 Christopher H. Poynton
  • 👤 Christopher L. Reading

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-08 18:13
CPC Classifications
B; B03; B03C; B03C1/00; B03C1/005; B03C1/01; A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5094; A61M; A61M1/00; A61M1/36; A61M1/3618; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; G01N33/54326; G01N33/5434; G01N2333/00; G01N2333/435; G01N2333/76; G01N2446/00; G01N2446/20; G01N2446/30; G01N2446/80; G01N2446/84

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 30 words
A biological magnetic liquid comprising a magnetic colloidal disperse phase distributed through a liquid dispersion medium, said disperse phase including fine magnetic particles coated with a cross-linked biologically compatible polymer.
Claim 2
Dependent Claim 30 words
A biological magnetic liquid comprising a magnetic colloidal disperse phase distributed through a liquid dispersion medium, said disperse phase including fine magnetic particles coated with a cross-linked biologically compatible polymer.
Claim 3
Dependent Claim 19 words
A liquid according to claim 1, wherein said magnetic particles include magnetite cobalt and/or boron as a substantial component.
Claim 4
Dependent Claim 15 words
A liquid according to claim 1, wherein said biologically compatible polymer is a biological polymer.
Claim 5
Dependent Claim 20 words
A liquid according to claim 1, wherein said liquid dispersion medium is an aqueous solution formed substantially of physiological salts.
Claim 6
Dependent Claim 18 words
A liquid according to claim 1, including a covalent linking agent connected to said cross-linked biologically compatible polymer.
Claim 7
Dependent Claim 15 words
A liquid according to claim 1, wherein antibodies are connected via said covalent linking agent.
Claim 8
Dependent Claim 33 words
A biological magnetic liquid comprising a magnetic colloidal disperse phase distributed throughout a liquid dispersion medium, said disperse phase including magnetic particles comprising biologically compatible polymer and cobalt and optionally another magnetic metal.
Claim 9
Dependent Claim 33 words
A biological magnetic liquid comprising a magnetic colloidal disperse phase distributed throughout a liquid dispersion medium, said disperse phase including magnetic particles comprising biologically compatible polymer and cobalt and optionally another magnetic metal.
Claim 10
Independent Claim 43 words
A method of making a biological magnetic liquid comprising the steps of: (a) forming a biologically incompatible colloid, and (b) slowly adding the colloid to a liquid, low salt biological polymer, such as to avoid substantial aggregation to form a biologically compatible colloid.
Claim 11
Independent Claim 43 words
A method of making a biological magnetic liquid comprising the steps of: (a) forming a biologically incompatible colloid, and (b) slowly adding the colloid to a liquid, low salt biological polymer, such as to avoid substantial aggregation to form a biologically compatible colloid.
Claim 12
Dependent Claim 17 words
A method according to claim 8 including the step of subjecting the liquid to tangential flow ultrafiltration.
Claim 13
Dependent Claim 29 words
A method according to claim 8, including the step of forming a covalent linkage on said biologically compatible polymer to secure a colloidal particle to a biologically active macromolecule.
Claim 14
Dependent Claim 21 words
A method according to claim 10, including the step of connecting an antibody to said covalent linkage by way of immunoglobulin.
Claim 15
Independent Claim 26 words
A method according to any one of claims 8 to 11 which includes the steps of adding fetal bovine serum and then lyophilizing the magnetic liquid.
Claim 16
Dependent Claim 16 words
A lyophilized biological magnetic colloid comprising magnetic colloidal particles coated with a cross-linked biologically compatible polymer.
Claim 17
Dependent Claim 16 words
A lyophilized biological magnetic colloid comprising magnetic colloidal particles coated with a cross-linked biologically compatible polymer.
Claim 18
Dependent Claim 11 words
A colloid according to claim 13 including lyophilized fetal bovine serum.
Claim 19
Dependent Claim 20 words
A colloid according to claim 13 or 14, wherein the particles are coated with cobalt and a biologically compatible polymer..

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag